Login / Signup

Anticholinergic medications for reducing drooling in children with developmental disability.

Susan M ReidChristine WestburyAngela T GuzysDinah Susan Reddihough
Published in: Developmental medicine and child neurology (2019)
In drooling, glycopyrrolate produced the greatest improvement with fewer side effects compared with benzhexol and scopolamine. Poor head control and poor oromotor function were associated with poor response. Medication side effects were common and often led to treatment discontinuation. Behavioural issues instigated cessation of benzhexol more often in males than females.
Keyphrases
  • multiple sclerosis
  • young adults
  • healthcare
  • adverse drug
  • optic nerve
  • replacement therapy
  • electronic health record